1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Clavis Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML) Elacytarabine, Investigator's Choice - Acute Myeloid Leukemia (AML) | Phase 3 | Completed | Clavis Pharma | 381 | 2010-06-01 | 2013-09-27 |
Australia (1) · Belgium (1) · Canada (1) · France (1) · Germany (1) · Ireland (1) · Italy (1) · Norway (1) · Poland (1) · Romania (1) · Spain (1) · United Kingdom (1) · United States (1)
David Rizzieri, MD (1) · Francis J Giles, MD, PhD (1)